News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chivukula Pad
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $25.6123, valued at
$128.1k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $34.91, valued at
$174.6k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/18/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 25,000 shares
@ $35.01, valued at
$875.3k
|
|
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $28.75, valued at
$143.8k
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $25.38, valued at
$126.9k
|
|
| 03/08/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $16.07, valued at
$80.4k
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 8,100 shares
@ $40, valued at
$324k
|
|
| 12/20/2021 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 3,633 shares
@ $40.0021, valued at
$145.3k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 10,000 shares
@ $44.41, valued at
$444.1k
|
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 10,000 shares
@ $40.07, valued at
$400.7k
|
|
| 04/05/2021 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 10,000 shares
@ $42.95, valued at
$429.5k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 100,000 options to buy
@ $99.29, valued at
$9.9M
|
|
| 12/03/2020 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 10,000 shares
@ $96.19, valued at
$961.9k
|
|
| 11/03/2020 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 10,000 shares
@ $55.28, valued at
$552.8k
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2020 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 10,000 shares
@ $45.16, valued at
$451.6k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
3
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 3 on Arcturus Therapeutics Ltd. |
| 02/22/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|